Navigation Links
Developing Quality in the Asian Pharmaceutical Industry Begins with QbD
Date:12/2/2013

KUALA LUMPUR, Dec. 2, 2013 /PRNewswire/ -- As Asia emerges as a major engine of global economic growth, the pharmaceutical and biotechnology industries in the region are expected to experience intensified competition. According to the Economist Intelligence Unit (EIU), regional pharmaceutical sales are expected to hit USD386bn, reflecting an annual average growth rate of more than 13%.

(Logo: http://www.prnasia.com/sa/2010/04/19/20100419602891.jpg )

Therefore, competition is likely to remain intense. The incorporation of Quality by Design (QbD) in the manufacturing process will help propel regional manufacturers to achieve quality and cost effectiveness to successfully compete in this growing market. Mr. Valentino Dhiyu, Formulator, Invida notes, "Product and process development account for 15-30% of overall R&D expenditure. Based on the experience of some companies, organisations that embrace QbD can significantly reduce costs, improve products, shorten time to launch, reduce risk, and improve patient benefits."

CPhI -- Quality by Design is a three-day technical event from 24-26 February 2014 in Kuala Lumpur, Malaysia that includes an exclusive two-day workshop, "Quality by Design Implementation Roadmap Masterclass". The event will address business drivers, regulatory frameworks, risks, principles and approach for QbD by speakers from both regulators and manufacturers such as the Food and Drug Administration - Philippines, Biocon and Invida. 

Mr. Nitin Madhukar Kadam, Assistant Manager R&D (Formulation), Medica Pharmaceutical Industries commented, "Asia has a huge landscape to grow and implement the QbD concept because the new era of approaches to quality has just began to harmonise global quality pharmaceuticals." CPhI -- Quality by Design is an opportunity for those in the pharmaceutical research and development, formulation, analytical, regulatory affairs and quality areas to explore and integrate QbD to in their organisations and building quality into product development.

For more information about CPhI -- Quality by Design, please visit: http://www.qualitybydesign-asia.com

Media Contact:

Marcus Chan
Senior Marketing Associate (ASEAN)
DID: +603-2176-8703
HP: +6012-227-7286
E-mail: Marcus.chan@ubm.com

About CPhI:

CPhI Conferences deliver the latest pharma market insight, in-depth case studies and exceptional networking opportunities through a programme of high-level conferences. The worldwide series of events, spanning four continents, provides the optimum forum for you to learn, make new business connections and identify the latest growth opportunities. 

Delivered by expert teams in each region, every conference is extensively researched with leading professionals, ensuring that CPhI Conferences tackle the most business critical issues facing the pharma industry today.

For more information about CPhI, please visit - www.cphiconferences.com

About the Organiser

UBM is a global live media and B2B communications, marketing service and data provider. We help organisations make connections, communicate their proposition and do business effectively. We enable professional people in more than 40 countries around the world to connect and engage with each other, with the markets they serve and with the information they need to succeed. And we do this by whatever means works best -- at live events, through digital media or in publications.

Our 6,500 expert staff are deeply embedded in the many specialist communities we serve, bringing both an unusual depth of understanding and real know-how. We organise hundreds of live events each year; we provide data, marketing and information products; we offer a portfolio of market-leading online and print titles; and we support professional communicators through our targeting, distribution and monitoring services.

Our culture of innovation and collaboration brings our people together around common interests to create value, enhancing our ability to do exactly the same for UBM customers. So, whatever their business and wherever they operate, our customers do better business through us.

For more information about UBM, please visit - http://www.ubm.com


'/>"/>
SOURCE UBM Conferences (ASEAN)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Developing High-Value Competitive Intelligence Functions in the Pharmaceutical Industry
2. New Pharmaceutical Product Launch Spend: Developing Competitive Launch and Pre-launch Budgets to Ensure a Successful Market Entry
3. Frost & Sullivan Lauds LI-COR Biosciences for Developing NIR Fluorescence, One of the Most Remarkable Advancements in the Biomedical Industry
4. GSMA mHealth Grand Tour Highlights How Mobile Technology Could Help Prevent 5 Million People In The EU From Developing Diabetes
5. XBiotech Announces it is Developing Therapy for MRSA
6. FDA Clears Hologics Single Energy Femur Exam to Visualize Features Associated with Developing Atypical Femur Fractures on a DXA Platform
7. Global Good and AUCMA Partner to Commercialize Vaccine Storage Invention for Developing Countries
8. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
9. IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries
10. Foundation Venture Capital Group Invests In Company Developing Implantable Meniscus for Knee Repair
11. Global Market for Medical Device Electrodes to Reach $1.43 billion, Technological Innovations and Developing Markets Fuel Demand for Neurological Monitoring and Digital Radiography
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):